Tenth International Conference on Progress in Vaccination Against Cancer (PIVAC 10), Cambridge, UK, 27th-30th September 2010: New hopes and strategies for cancer vaccines.
- Published in:
- 2011
- By:
- Publication type:
- Report
Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 8
Results: 15
1
2
CTLA-4 blockade increases antigen-specific CD8 T cells in prevaccinated patients with melanoma: three cases.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1137, doi. 10.1007/s00262-011-1011-9
- By:
- Publication type:
- Article
3
Targeting the extrinsic apoptosis signaling pathway for cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1173, doi. 10.1007/s00262-011-1008-4
- By:
- Publication type:
- Article
4
Camouflage and sabotage: tumor escape from the immune system.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1161, doi. 10.1007/s00262-011-1012-8
- By:
- Publication type:
- Article
5
Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1127, doi. 10.1007/s00262-011-0985-7
- By:
- Publication type:
- Article
6
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1075, doi. 10.1007/s00262-011-1021-7
- By:
- Publication type:
- Article
7
Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1085, doi. 10.1007/s00262-011-1013-7
- By:
- Publication type:
- Article
8
Cooperativity of adaptive and innate immunity: implications for cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1061, doi. 10.1007/s00262-011-1053-z
- By:
- Publication type:
- Article
9
Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1109, doi. 10.1007/s00262-011-1025-3
- By:
- Publication type:
- Article
10
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1153, doi. 10.1007/s00262-011-1026-2
- By:
- Publication type:
- Article
11
DNA fusion vaccines enter the clinic.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1147, doi. 10.1007/s00262-011-1042-2
- By:
- Publication type:
- Article
12
Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1195, doi. 10.1007/s00262-011-1050-2
- By:
- Publication type:
- Article
13
Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1097, doi. 10.1007/s00262-011-1023-5
- By:
- Publication type:
- Article
14
Polyfunctionality of a DKK1 self-antigen-specific CD8 T lymphocyte clone in lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1119, doi. 10.1007/s00262-011-1055-x
- By:
- Publication type:
- Article
15
Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 8, p. 1181, doi. 10.1007/s00262-011-1065-8
- By:
- Publication type:
- Article